Stockreport

Wall Street Analysts Predict a 34.41% Upside in Kymera Therapeutics (KYMR): Here's What You Should Know [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $48.79 indicates a 34.4% upside potential. The [Read more]